FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA

Glaxosmithkline S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 66d361637aa574c2
Drug Cima Aemps Name: FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Register Number: 90137
Holder Company Name: Glaxosmithkline S.A.
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/cf0469e91767f60e/glaxosmithkline-sa
Marketing Company Detail Path: /organization/cf0469e91767f60e/glaxosmithkline-sa
Authorization Date: 2025-02-13
Dosage Form: SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 0,5 ml
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Glaxosmithkline S.A.
Company Detail Path: /organization/cf0469e91767f60e/glaxosmithkline-sa

VIRUS INFLUENZA GRIPE A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVADO

15 Microgramo(s) Hemaglutinina

VIRUS INFLUENZA GRIPE A/THAILAND/8/2022 (H3N2) IVR-237 CEPA SIMILAR A (A/THAILAND/8/2022)

15 Microgramo(s) Hemaglutinina

VIRUS INFLUENZA GRIPE CEPA SIMILAR A B/AUSTRIA/1359417/2021-(B/AUSTRIA/1359417/2021, BVR-26)

15 Microgramo(s) Hemaglutinina

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 13, 2025

Approval ID

66d361637aa574c2

Type

Standard